Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

导出 OA

翻译打印收藏纠错

作者： Gautier,Marcq ^[1] ; Edouard,Jarry ^[2] ; Idir,Ouzaid ^[3] ; Jean-François,Hermieu ^[3] ; François,Henon ^[2] ; Jean-Christophe,Fantoni ^[2] ; Evanguelos,Xylinas ^[3]

作者单位： CHU Lille, Urology department, Rue Michel Polonovski, Hôpital Claude Huriez, F-59000, Lille, France. ^[1] Urology department, Hôpital Claude Huriez, Lille, France. ^[2] Department of Urology, Paris Descartes University, Paris, France. ^[3]

关键词 immunotherapy muscle-invasive bladder cancer neoadjuvant chemotherapy (NAC)platinum-based chemotherapy

DOI 10.1177/1756287218823678

PMID 30728860

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in urology

1756287218823678页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Therapeutic advances in urology

相似文献

Therapeutic advances in urology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Therapeutic advances in urology

相似文献

Therapeutic advances in urology

相关期刊

检索历史清除